Jane Lowe Meisel

4.0k citations
90 papers · 2.8k · 3 hit papers · h-index 23

Impact in

    • Parasitic Infections and Diagnostics
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

    • HER2/EGFR in Cancer Research 18
    • Cancer Treatment and Pharmacology 6
    • Breast Cancer Treatment Studies 16
    • Cancer Genomics and Diagnostics 8

Jane Lowe Meisel

81 papers receiving 2.6k citations

Jane Lowe Meisel's Hit Papers

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer 2024 · 79 citations
790+16+33Years since publication100200300

Peers

Jane Lowe Meisel
Comparison fields: 5 of 115
  • Parasitology 315
  • Cancer Research 596
  • Oncology 1.0k
  • Reproductive Medicine 140
  • Pulmonary and Respiratory Medicine 452
Replace Rodolfo Laucirica with:
Rodolfo Laucirica United States
Krittika Suwanrungruang Thailand
Edwin P. Rock United States
Simonetta Mocci United States
Kelly J. Yu United States
Robert Poppiti United States
Jian Zhou China
Lorraine Cheryl Pelosof United States
Aarti Sharma United Kingdom
Richard W. Cartun United States
Jane Lowe Meisel relative to Rodolfo Laucirica United States Rodolfo Laucirica's profile →
Citations per field
00.5×2×4×6×8×9.3×
Rodolfo Laucirica · 1×
Citations per year

Countries citing papers authored by Jane Lowe Meisel

Since Specialization
Citations

This map shows the geographic impact of Jane Lowe Meisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Lowe Meisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Lowe Meisel more than expected).

Fields of papers citing papers by Jane Lowe Meisel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Lowe Meisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Lowe Meisel. The network helps show where Jane Lowe Meisel may publish in the future.

Co-authors

The 25 scholars most cited alongside Jane Lowe Meisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jane Lowe Meisel Line = papers co-authored together Jane Lowe Meisel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016416
2
Overwhelming Watery Diarrhea Associated with a Cryptosporidium in an Immunosuppressed Patient
Hit paper breakdown →
1976362
3
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Hit paper breakdown →
2022321
4 2017207
5 2020134
6 1977119
7 1981115
8 201683
9
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer
Hit paper breakdown →
202479
10 202177
11 202167
12 201464
13 201952
14 201849
15 201444
16 201537
17 201433
18 201930
19 202327
20 201826

About Jane Lowe Meisel

Jane Lowe Meisel is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 90 papers that have together received 2.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Advanced Breast Cancer Therapies (17 papers), Breast Cancer Treatment Studies (16 papers), Cancer Genomics and Diagnostics (8 papers), BRCA gene mutations in cancer (8 papers), Cancer Treatment and Pharmacology (6 papers), Estrogen and related hormone effects (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Parasitology (315 citations), Cancer Research (596 citations), Oncology (1.0k citations), Reproductive Medicine (140 citations) and Pulmonary and Respiratory Medicine (452 citations). Jane Lowe Meisel has collaborated with scholars based in United States, China and Australia. Frequent co-authors include C.E. Rubin, David R. Perera, Xiaoxian Li, Limin Peng, Ruth M O'Regan, Jing Liang Yang, Mylin Ann Torres, Lei Huo, Ayşegül A. Şahin and David R. Saunders. Their work appears in journals such as Breast Cancer Research and Treatment, Clinical Breast Cancer, Annals of Oncology, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact